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SHORT COMMUNICATION
A skin condition that is scratched open, sometimes subty-
ped by the adjective “excoriée”, is a feature of a number 
of skin diseases, such as acne and atopic dermatitis. The 
consequences of excoriation can be extreme in patients 
with fragile skin, such as epidermolysis bullosa (EB), in 
which scratching rapidly leads to wounds. Pruritus can 
manifest in all forms of EB secondary to wound healing. 
In a primary form it is seen in patients with dominant 
dystrophic EB (DDEB) due to glycine substitution 
mutations in the COL7A1 gene (1), a subtype known as 
EB pruriginosa (EBP) (2). EBP occurs in young adults 
and starts with pruritus of EB lesions, most often in the 
pretibial area, with compulsive scratching leading to 
lichenoid, violaceous papules and plaques (2). In patients 
in whom bulla formation is not prominent, EBP can 
easily be misdiagnosed as hypertrophic lichen planus 
or psychogenic pruritus (3). We report here 2 young 
women affected by EBP and pruritus on the face and 
upper chest, a presentation not previously reported in 
the literature. What was remarkable in these 2 unrelated 
patients is that the itch did not start pretibially, nor did 
it lead to violaceous papules and plaques. The itch was 
not secondary to EB lesions, but was localized to intact 
non-inflamed skin of the face and upper chest. The ex-
coriations, which resulted from compulsive scratching, 
strongly resembled neurotic artefacts.
CASE REPORTS
Patient 1, a 21-year-old woman with DDEB caused by a he-
terozygous glycine substitution c.6227G>T, p.Gly2076Val in 
COL7A1. Her EB lesions were localized acrally. The patient 
was seen for exacerbation of facial atopic dermatitis. Conven-
tional therapy, including topical corticosteroids, calcineurin 
inhibitors and emollients, as well as cyclosporine, had little 
or no effect; her pruritus became unbearable, and she reported 
scratching in her sleep. To attempt to prevent her from scrat-
ching, we provided a physical barrier for the patient’s face; a 
custom made perforated silicone mask worn at night. However, 
the mask worsened the pruritus due to condensation and heat 
accumulation. The patient was regularly seen with progressive 
seething wounds, crusts (Fig. 1) and scar tissue formation on 
her face (not shown). Clinically, the lesions resembled neurotic 
excoriations. Psychological examination revealed no psycho-
pathological base consistent with self-inflicted compulsive 
disorders that the patient denied (dermatitis artefacta) or admit-
ted (automutilation). 
Patient 2, a 22-year-old woman with DDEB caused by a he-
terozygous glycine substitution c.6128G>A, p.Gly2043Glu in 
COL7A1, had had acne excoriée des jeunes filles in addition to 
EB since 11 years of age. After using oral contraceptives, her 
acne lesions (comedones and pustules) disappeared. However, 
the patient returned to our clinic with severe itch in her face 
and upper chest. Relief with topical calcineurin inhibitors and 
corticosteroids, and oral antibiotics was short-lived. Compul-
sive scratching of clinically healthy, non-inflamed skin after 
several weeks resulted in erythematous, excoriated papules, 
scabs and scars in the face (Fig. 1B). Persisting acne excoriée 
Epidermolysis Bullosa Pruriginosa Excoriée: A Deceptive Pruritic Variant in Two Female Patients
Katarzyna B. Gostyńska and Marcel F. Jonkman
Center for Blistering Diseases and Department of Dermatology, University of Groningen, University Medical Center Groningen, AB 21, PO Box 30.001, 
NL-9700 RB Groningen, The Netherlands. E-mail: k.gostynska@umcg.nl
Accepted May 27, 2015; Epub ahead of print Jun 3, 2015
Fig. 1. Both patients seen at  initial consultation. (A) 
Patient 1, with erythematous linear excoriations and 
scabs with secondary impetiginization localized on the 
face. (B) Patient 2, with erythematous macules, crusts 
and scabs localized on the face. (C) Albopapuloid 
papules and atrophic scars typical for epidermolysis 
bullosa pruriginosa (EBP) on the upper chest. The 
patients gave  permission to publish the photographs.
141Short communication
des jeunes filles was ruled out since comedones and pustules 
were absent. Consultation with a psychologist revealed no 
neurotic psychopathology. Scratching of her upper chest, but 
not her face, had evolved to shiny papules and plaques with 
scarring pathognomonic lesions of EBP (Fig. 1C).
DISCUSSION
Traditional EBP is seen clinically as linear hypertrophic 
scarring and lichenified plaques, occurring most com-
monly on the forearms and lower legs (2). 
In both cases a diagnosis of atypical EBP with facial 
involvement, EBP-excoriée, was made. Prior to the 
development of itch on the face, both patients had had 
albopapuloid lesions, milia and skin blistering localized 
acrally on the chest, in the cubital and popliteal fossa, 
since childhood; all typical of DDEB. The pretibial 
region was spared. Due to the fragility of the skin, 
compulsive scratching of the face easily resulted in dra-
matic excoriations that mimicked neurotic artefacts (3). 
Atopic, acneiform and psychogenic causes were ruled 
out in both patients. Suggested therapeutic options for 
EBP, including the anti-inflammatory agents and im-
munomodulators already mentioned, were prescribed, 
but provided little or no relief. Persisting pruritus was 
observed during the 2-year follow-up. Both young 
women had periods of relief from itch, not associated 
with any of the treatments applied; however, the pruritus 
remains refractory. Lesions on the face have now healed 
with small atrophic scars that are not typical for EBP. 
The aetiology of itch in EBP remains unknown. Cases 
continue to be reported of DEB patients with glycine 
substitution mutations in COL7A1 (4). Internal diseases, 
mineral deficiencies and associations with atopy have 
all proven inconclusive. The presence of itch on clini-
cally healthy, non-affected skin by our 2 patients with 
EBP-excoriée is difficult to explain. It is known that 
patients with chronic pruritic skin diseases, such as 
psoriasis and atopic dermatitis, experience feelings of 
helplessness and increased anxiety, which, in turn, can 
perpetuate perceived itch (5). One might speculate that 
such a socially stigmatizing disease as is EB, caused 
itch to be perceived on non-lesional skin in the face, 
therefore starting the vicious cycle of itching and scrat-
ching. As described by both young women, chronic 
lesions located on the body were also itchy; however, 
to a lesser extent than on the face. Further studies exa-
mining larger EBP cohorts must be performed in order 
to consider other aetiologies.
EBP has been classified by the International Forum 
for the Study of Itch (IFSI) into Group I, pruritus on 
primary diseased, inflamed skin (6). However, our cases 
demonstrate that violaceous hypertrophic papules and 
plaques, as typically seen on the shins in classic EBP, 
do not always form. We therefore conclude that EBP can 
manifest with pruritus on primary normal, non-inflamed 
skin, classified as IFSI Group II, in the form of EBP-
excoriée. Consequently, it can evolve into IFSI Group 
III, pruritus with chronic secondary scratch lesions with 
typical EBP presentation. The atypical presentation of 
EBP will undoubtedly challenge physicians even more 
than classic EBP. EBP should be considered when 
encountering a patient with clinical characteristics of 
fragile skin with blistering, nail dystrophy and milia in 
patients (and family members), which are almost always 
present. Frequently reported sites of predilection for 
albopapuloid lesions and hypertrophic scarring of EBP 
are the shins (3); however, as seen in the excoriée vari-
ant, these features may be absent. Unexplained pruritus 
and excoriations mimicking artefacts should prompt 
physicians to consider EBP in the differential diagnosis, 
especially in younger patients. When encountering a 
patient with such clinical findings, immunofluorescence 
antigen mapping of type VII collagen may indicate 
the underlying genetic disorder; however, this may be 
inconclusive in patients with mild phenotypes. Diag-
nosis of EBP should always be confirmed by genetic 
sequencing of COL7A1 (3).
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